Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
D058892:Adenosine Deaminase Inhibitors; D000255:Adenosine Triphosphate / Q000378:metabolism; D000970:Antineoplastic Agents / Q000378:metabolism; D002478:Cells, Cultured; D003070:Coformycin / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D013601:T-Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology* / Q000633:toxicity
D058892:Adenosine Deaminase Inhibitors; D000970:Antineoplastic Agents; D003070:Coformycin; D000255:Adenosine Triphosphate; D004247:DNA; D014740:Vidarabine; C024352:fludarabine